Skip to content

ABOUT
TREATMENT AS
PREVENTION®
HOPE TO HEALTH
RESEARCH & INNOVATION
CENTRE
DRUG TREATMENT
PROGRAMS
RESEARCH

ABOUT
TREATMENT AS
PREVENTION®
HOPE TO HEALTH
RESEARCH & INNOVATION
CENTRE
DRUG TREATMENT
PROGRAMS
RESEARCH

Dear Doctor Letter

BC-CfE Resources for Providers (Poster)

BC-CfE Resources for Providers (Poster) Read More »

Doxycycline for Bacterial STI Prevention

Click here to link to information about this initiative

Doxycycline for Bacterial STI Prevention Read More »

Cabotegravir and Rilpivirine Extended-Release Injectable Suspensions (Cabenuva^(R))

Cabotegravir and Rilpivirine Extended-Release Injectable Suspensions (Cabenuva(R)) Considerations for the Prescriber (June, 2023) Considerations for the Client (May, 2023)

Cabotegravir and Rilpivirine Extended-Release Injectable Suspensions (Cabenuva^(R)) Read More »

Doravirine (Pifeltro(R)) and Doravirine-lamivudine-tenofovir disoproxil fumarate (Delstrigo(R))

Doravirine (Pifeltro(R)) and Doravirine-lamivudine-tenofovir disoproxil fumarate (Delstrigo(R)) Read More »

Repeat Fill Authorization Permitted on BC-CfE Antiretroviral Prescriptions for the Treatment of HIV Infection

Repeat Fill Authorization Permitted on BC-CfE Antiretroviral Prescriptions for the Treatment of HIV Infection Read More »

Updates to BC-CfE HIV Drug Treatment and Prevention Programs

Formulary Addition: Dolutegravir-lamivudine (Dovato®) Resumption of routine HIV plasma viral load testing Updates to BC-CfE Guidance Documents

Updates to BC-CfE HIV Drug Treatment and Prevention Programs Read More »

Guideline for Antiretroviral Therapy (ART) Regimens for Initial Therapy and for Switching ART in Virologically Stable Suppressed Adults

Guideline for Antiretroviral Therapy (ART) Regimens for Initial Therapy and for Switching ART in Virologically Stable Suppressed Adults Read More »

BC Ministry of Health Directive to Include Antiretrovirals on PharmaNet

BC Ministry of Health Directive to Include Antiretrovirals on PharmaNet Read More »

BC-CfE AND COVID-19: HIV Treatment and Prevention Programs Update

BC-CfE AND COVID-19: HIV Treatment and Prevention Programs Update Read More »

COVID-19 and how it will affect Precision Medicine testing

COVID-19 and how it will affect Precision Medicine testing Read More »

Post pagination

Privacy Notice|Privacy Statement|Personal Information Banks|Website Privacy Policy

© 2024 British Columbia Centre for Excellence
St. Paul's Hospital 608–1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
Tel: 604-806-8477 | Fax: 604-806-9044
General inquiries: info@bccfe.ca
Media inquiries: communications@bccfe.ca

(Please do not use any of these email addresses to send personal information or book an appointment.
To book appointments or contact the H2H clinic, please call 604-416-1517 or fax: 604-564-4893.
Do not send your or your client's personal information via email.)

Scroll to Top

CLICK FOR CANADA POST NOTICE

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

Start typing and press enter to search

Search...